Skip to main content
Erschienen in: Journal of Cachexia, Sarcopenia and Muscle 2/2014

01.06.2014 | Review

An overview of amines as nutritional supplements to counteract cancer cachexia

verfasst von: Patrícia Lopes de Campos-Ferraz, Isabel Andrade, Willian das Neves, Isabela Hangai, Christiano Robles Rodrigues Alves, Antonio Herbert Lancha Jr

Erschienen in: Journal of Cachexia, Sarcopenia and Muscle | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Cancer cachexia is a complex multifactorial syndrome characterized by loss of skeletal muscle mass (with or without loss of fat mass) that cannot be fully reversed by conventional nutritional support and leads to progressive functional impairment. Recently, some amino acids and other amine dietary supplements have been highlighted in medical field due to positive effects upon diseases evolving skeletal muscle atrophy. Therefore, the aim of this brief review is to discuss the putative application of amines as dietary supplements to counteract skeletal muscle wasting on cancer cachexia. Specifically, we focus in two nutritional supplements: (1) branched-chain amino acids (BCAAs) and (2) creatine. Both BCAAs and creatine may attenuate proteolysis and enhance proteins synthesis in skeletal muscle. Although more experimental studies and clinical trials are still necessary to elucidate this therapeutic application, several evidences have demonstrated that amines supplementation is a promising coadjuvant treatment to cancer cachexia.
Literatur
1.
Zurück zum Zitat Tan BHL, Fearon KC. Cachexia: prevalence and impact in medicine. Curr Opin Clin Nutr Metab Care. 2008:11:400–07. Tan BHL, Fearon KC. Cachexia: prevalence and impact in medicine. Curr Opin Clin Nutr Metab Care. 2008:11:400–07.
2.
Zurück zum Zitat Warren S. The immediate cause of death in cancer. Am J Med Sci. 1932;184:610–13. Warren S. The immediate cause of death in cancer. Am J Med Sci. 1932;184:610–13.
4.
Zurück zum Zitat Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489–95.PubMedCrossRef Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489–95.PubMedCrossRef
5.
Zurück zum Zitat Fearon KC, Glass DJ, Guttridge DC. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab. 2012;16:153–66.PubMedCrossRef Fearon KC, Glass DJ, Guttridge DC. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab. 2012;16:153–66.PubMedCrossRef
6.
Zurück zum Zitat Argilés JM, López-Soriano FJ, Busquets S. Mechanisms and treatment of cancer cachexia. Nutr Metab Cardiovasc Dis. 2013;23(S1):S19–S24. Argilés JM, López-Soriano FJ, Busquets S. Mechanisms and treatment of cancer cachexia. Nutr Metab Cardiovasc Dis. 2013;23(S1):S19–S24.
7.
Zurück zum Zitat de Campos-Ferraz PL, Ribeiro SM, Luz SS, Lancha Jr AH, Tirapegui J. Exercise x BCAA supplementation in young trained rats: What are their effects on body growth? J Sports Sci Med. 2011;10:483–90. de Campos-Ferraz PL, Ribeiro SM, Luz SS, Lancha Jr AH, Tirapegui J. Exercise x BCAA supplementation in young trained rats: What are their effects on body growth? J Sports Sci Med. 2011;10:483–90.
8.
Zurück zum Zitat Wilson GJ, Wilson JM, Manninen AH. Effects of beta-hydroxy-beta-methylbutyrate (HMB) on exercise performance and body composition across varying levels of age, sex, and training experience: a review. Nutr Metab (Lond). 2008;5:1. Wilson GJ, Wilson JM, Manninen AH. Effects of beta-hydroxy-beta-methylbutyrate (HMB) on exercise performance and body composition across varying levels of age, sex, and training experience: a review. Nutr Metab (Lond). 2008;5:1.
9.
Zurück zum Zitat Tarnopolsky MA. Creatine as a therapeutic strategy for myopathies. Amino Acids. 2011;40:1397–407.PubMedCrossRef Tarnopolsky MA. Creatine as a therapeutic strategy for myopathies. Amino Acids. 2011;40:1397–407.PubMedCrossRef
10.
Zurück zum Zitat Nicastro H, Artioli GG, Costa Ados S, Solis MY, da Luz CR, Blachier F, et al. An overview of the therapeutic effects of leucine supplementation on skeletal muscle under atrophic conditions. Amino Acids. 2011;40:287–300.PubMedCrossRef Nicastro H, Artioli GG, Costa Ados S, Solis MY, da Luz CR, Blachier F, et al. An overview of the therapeutic effects of leucine supplementation on skeletal muscle under atrophic conditions. Amino Acids. 2011;40:287–300.PubMedCrossRef
11.
Zurück zum Zitat Wagenmakers AJ. Amino acid metabolism, muscular fatigue and muscle wasting, Speculation on adaptations at high altitude. Int J Sports Med. 1992;13:S110–3.PubMedCrossRef Wagenmakers AJ. Amino acid metabolism, muscular fatigue and muscle wasting, Speculation on adaptations at high altitude. Int J Sports Med. 1992;13:S110–3.PubMedCrossRef
12.
Zurück zum Zitat Choudry HA, Pan M, Karinch AM, Souba WW. Branched-chain amino acid-enriched nutritional support in surgical and cancer patients. J Nutr. 2006;136:314S–8S.PubMed Choudry HA, Pan M, Karinch AM, Souba WW. Branched-chain amino acid-enriched nutritional support in surgical and cancer patients. J Nutr. 2006;136:314S–8S.PubMed
13.
Zurück zum Zitat Bourgeois JM, Nagel K, Pearce E, Wright M, Barr RD, Tarnopolsky MA. Creatine monohydrate attenuates body fat accumulation in children with acute lymphoblastic leukemia during maintenance chemotherapy. Pediatr Blood Cancer. 2008;51:183–7.PubMedCrossRef Bourgeois JM, Nagel K, Pearce E, Wright M, Barr RD, Tarnopolsky MA. Creatine monohydrate attenuates body fat accumulation in children with acute lymphoblastic leukemia during maintenance chemotherapy. Pediatr Blood Cancer. 2008;51:183–7.PubMedCrossRef
14.
Zurück zum Zitat Patra S, Ghosh A, Roy SS, Bera S, Das M, Talukdar D, et al. A short review on creatinecreatine kinase system in relation to cancer andsome experimental results on creatineas adjuvant in cancer therapy. Amino Acids. 2012;42:2319–30.PubMedCrossRef Patra S, Ghosh A, Roy SS, Bera S, Das M, Talukdar D, et al. A short review on creatinecreatine kinase system in relation to cancer andsome experimental results on creatineas adjuvant in cancer therapy. Amino Acids. 2012;42:2319–30.PubMedCrossRef
15.
Zurück zum Zitat Baracos VE, Mackenzie ML. Investigations of branched-chain amino acids and their metabolites in animal models of cancer. J Nutr. 2006;136:237S–42S.PubMed Baracos VE, Mackenzie ML. Investigations of branched-chain amino acids and their metabolites in animal models of cancer. J Nutr. 2006;136:237S–42S.PubMed
16.
Zurück zum Zitat Aversa Z, Bonetto A, Costelli P, Minero VG, Penna F, Baccino FM, Lucia S, Rossi Fanelli F, Muscaritoli M. ß-hydroxy-ß-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia. Int J Oncol. 2011;38:713–720. Aversa Z, Bonetto A, Costelli P, Minero VG, Penna F, Baccino FM, Lucia S, Rossi Fanelli F, Muscaritoli M. ß-hydroxy-ß-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia. Int J Oncol. 2011;38:713–720.
17.
Zurück zum Zitat Nicastro H, da Luz CR, Chaves DF, Bechara LR, Voltarelli VA, Rogero MM, Lancha AH Jr. Does branched chain amino acids supplementation modulate skeletal muscle remodeling through inflammation modulation? Possible mechanisms of action. J Nutr Metab. 2012;136937 Nicastro H, da Luz CR, Chaves DF, Bechara LR, Voltarelli VA, Rogero MM, Lancha AH Jr. Does branched chain amino acids supplementation modulate skeletal muscle remodeling through inflammation modulation? Possible mechanisms of action. J Nutr Metab. 2012;136937
18.
Zurück zum Zitat Shimomura Y, Yamamoto Y, Bajotto G, Sato J, Murakami T, Shimomura N, et al. Nutraceutical effects of branched-chain amino acids on skeletal muscle. J Nutr. 2006;136:529S–32S.PubMed Shimomura Y, Yamamoto Y, Bajotto G, Sato J, Murakami T, Shimomura N, et al. Nutraceutical effects of branched-chain amino acids on skeletal muscle. J Nutr. 2006;136:529S–32S.PubMed
19.
Zurück zum Zitat Burke LM, Castell LM, Stear SJ. BJSM reviews: A-Z of supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance Part 1. Br J Sports Med. 2009;43:728–9.PubMedCrossRef Burke LM, Castell LM, Stear SJ. BJSM reviews: A-Z of supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance Part 1. Br J Sports Med. 2009;43:728–9.PubMedCrossRef
20.
Zurück zum Zitat Campos-Ferraz PL, Bozza T, Nicastro H, Lancha Jr AH. Distinct effects of leucine or a mixture of the branched-chain amino acids (leucine, isoleucine, and valine) supplementation on resistance to fatigue, and muscle and liver-glycogen degradation, in trained rats. Nutrition. 2013;29:1388–94.PubMedCrossRef Campos-Ferraz PL, Bozza T, Nicastro H, Lancha Jr AH. Distinct effects of leucine or a mixture of the branched-chain amino acids (leucine, isoleucine, and valine) supplementation on resistance to fatigue, and muscle and liver-glycogen degradation, in trained rats. Nutrition. 2013;29:1388–94.PubMedCrossRef
21.
22.
Zurück zum Zitat Kawamura I, Sato H, Ogoshi S, Blackburn GL. Use of an Intravenous branched chain amino acid enriched diet in the tumor-bearing rat. Jpn J Surg. 1985;15:471–6.PubMedCrossRef Kawamura I, Sato H, Ogoshi S, Blackburn GL. Use of an Intravenous branched chain amino acid enriched diet in the tumor-bearing rat. Jpn J Surg. 1985;15:471–6.PubMedCrossRef
23.
Zurück zum Zitat Crosby LE, Bistrian BR, Ling PR, Istfan NW, Blackburn GL, Hoffman SB. Effects of branched chain amino acid-enriched total parenteral nutrition on amino acid utilization in rats bearing Yoshida sarcoma. Cancer Res. 1988;48:2698–702.PubMed Crosby LE, Bistrian BR, Ling PR, Istfan NW, Blackburn GL, Hoffman SB. Effects of branched chain amino acid-enriched total parenteral nutrition on amino acid utilization in rats bearing Yoshida sarcoma. Cancer Res. 1988;48:2698–702.PubMed
24.
Zurück zum Zitat Le Bricon T. Effects of administration of oral branched-chain amino acids on anorexia and caloric intake in cancer patients. Clin Nutr. 1996;15:337.PubMedCrossRef Le Bricon T. Effects of administration of oral branched-chain amino acids on anorexia and caloric intake in cancer patients. Clin Nutr. 1996;15:337.PubMedCrossRef
25.
Zurück zum Zitat Cangiano C, Laviano A, Meguid MM, Mulieri M, Conversano L, Preziosa I, et al. Effects of administration of oral branched-chain amino acids on anorexia and caloric intake in cancer patients. J Natl Cancer Inst. 1996;88:550–2.PubMedCrossRef Cangiano C, Laviano A, Meguid MM, Mulieri M, Conversano L, Preziosa I, et al. Effects of administration of oral branched-chain amino acids on anorexia and caloric intake in cancer patients. J Natl Cancer Inst. 1996;88:550–2.PubMedCrossRef
26.
Zurück zum Zitat Peters SJ, van Helvoort A, Kegler D, Argilès JM, Luiking YC, Laviano A, et al. Dose-dependent effects of leucine supplementation on preservation of muscle mass in cancer cachectic mice. Oncol Rep. 2011;26:247–54.PubMed Peters SJ, van Helvoort A, Kegler D, Argilès JM, Luiking YC, Laviano A, et al. Dose-dependent effects of leucine supplementation on preservation of muscle mass in cancer cachectic mice. Oncol Rep. 2011;26:247–54.PubMed
27.
Zurück zum Zitat Gomes-Marcondes MC, Ventrucci G, Toledo MT, Cury L, Cooper JC. A leucine-supplemented diet improved protein content of skeletal muscle in young tumor-bearing rats. Braz J Med Biol Res. 2003;36:1589–94.PubMedCrossRef Gomes-Marcondes MC, Ventrucci G, Toledo MT, Cury L, Cooper JC. A leucine-supplemented diet improved protein content of skeletal muscle in young tumor-bearing rats. Braz J Med Biol Res. 2003;36:1589–94.PubMedCrossRef
28.
Zurück zum Zitat Salomão EM, Toneto AT, Silva GO, Gomes-Marcondes MC. Physical exercise and a leucine rich diet modulate the muscle protein metabolism in Walker tumor-bearing rats. Nutr Cancer. 2010;62:1095–104.PubMedCrossRef Salomão EM, Toneto AT, Silva GO, Gomes-Marcondes MC. Physical exercise and a leucine rich diet modulate the muscle protein metabolism in Walker tumor-bearing rats. Nutr Cancer. 2010;62:1095–104.PubMedCrossRef
29.
Zurück zum Zitat Ventrucci G, Mello MA, Gomes-Marcondes MC. Proteasome activity is altered in skeletal muscle tissue of tumour-bearing rats a leucine-rich diet. Endocr Relat Cancer. 2004;11:887–95.PubMedCrossRef Ventrucci G, Mello MA, Gomes-Marcondes MC. Proteasome activity is altered in skeletal muscle tissue of tumour-bearing rats a leucine-rich diet. Endocr Relat Cancer. 2004;11:887–95.PubMedCrossRef
30.
Zurück zum Zitat Ventrucci G, Mello MA, Gomes-Marcondes MC. Leucine-rich diet alters the eukaryotic translation initiation factors expression in skeletal muscle of tumour-bearing rats. BMC Cancer. 2007;7:42.PubMedCentralPubMedCrossRef Ventrucci G, Mello MA, Gomes-Marcondes MC. Leucine-rich diet alters the eukaryotic translation initiation factors expression in skeletal muscle of tumour-bearing rats. BMC Cancer. 2007;7:42.PubMedCentralPubMedCrossRef
31.
Zurück zum Zitat Tayek JA, Bistrian BR, Hehir DJ, Martin R, Moldawer LL, Blackburn GL. Improved protein kinetics and albumin synthesis by branched chain amino acid-enriched total parenteral nutrition in cancer cachexia: a prospective randomized crossover trial. Cancer. 1986;58:147–57.PubMedCrossRef Tayek JA, Bistrian BR, Hehir DJ, Martin R, Moldawer LL, Blackburn GL. Improved protein kinetics and albumin synthesis by branched chain amino acid-enriched total parenteral nutrition in cancer cachexia: a prospective randomized crossover trial. Cancer. 1986;58:147–57.PubMedCrossRef
32.
Zurück zum Zitat Yamanaka H, Kanemaki T, Tsuji M, Kise Y, Hatano T, Hioki K, et al. Branched-chain amino acid-supplemented nutritional support after gastrectomy for gasric cancer with special reference to plasma amino acid profiles. Nutrition. 1990;6:241–5.PubMed Yamanaka H, Kanemaki T, Tsuji M, Kise Y, Hatano T, Hioki K, et al. Branched-chain amino acid-supplemented nutritional support after gastrectomy for gasric cancer with special reference to plasma amino acid profiles. Nutrition. 1990;6:241–5.PubMed
33.
Zurück zum Zitat Nunes EA, Kuczera D, Brito GA, Bonatto SJ, Yamazaki RK, Tanhoffer RA, et al. Beta-hydroxy-beta-methylbutyrate supplementation reduces tumor growth and tumor cell proliferation ex vivo and prevents cachexia in Walker 256 tumor-bearing rats by modifying nuclear factor-kappaB expression. Nutr Res. 2008;28:487–93.PubMedCrossRef Nunes EA, Kuczera D, Brito GA, Bonatto SJ, Yamazaki RK, Tanhoffer RA, et al. Beta-hydroxy-beta-methylbutyrate supplementation reduces tumor growth and tumor cell proliferation ex vivo and prevents cachexia in Walker 256 tumor-bearing rats by modifying nuclear factor-kappaB expression. Nutr Res. 2008;28:487–93.PubMedCrossRef
34.
Zurück zum Zitat Smith HJ, Wyke SM, Tisdale MJ. Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by beta-hydroxy-beta-methylbutyrate. Cancer Res. 2004;64:8731–5.PubMedCrossRef Smith HJ, Wyke SM, Tisdale MJ. Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by beta-hydroxy-beta-methylbutyrate. Cancer Res. 2004;64:8731–5.PubMedCrossRef
35.
Zurück zum Zitat Molfino A, Gioia G, Rossi Fanelli F, Muscaritoli M. Beta-hydroxy-beta-methylbutyrate supplementation in health and disease: a systematic review of randomized trials. Amino Acids. 2013;45:1273–92.PubMedCrossRef Molfino A, Gioia G, Rossi Fanelli F, Muscaritoli M. Beta-hydroxy-beta-methylbutyrate supplementation in health and disease: a systematic review of randomized trials. Amino Acids. 2013;45:1273–92.PubMedCrossRef
36.
Zurück zum Zitat Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev. 2000;80:1107–213.PubMed Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev. 2000;80:1107–213.PubMed
37.
Zurück zum Zitat Gualano B, Artioli GG, Poortmans JR, Lancha Junior AH. Exploring the therapeutic role of creatine supplementation. Amino Acids. 2010;38:31–44.PubMedCrossRef Gualano B, Artioli GG, Poortmans JR, Lancha Junior AH. Exploring the therapeutic role of creatine supplementation. Amino Acids. 2010;38:31–44.PubMedCrossRef
38.
Zurück zum Zitat Harris RC, Söderlund K, Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci (Lond). 1992;83:367–74. Harris RC, Söderlund K, Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci (Lond). 1992;83:367–74.
39.
40.
Zurück zum Zitat Alves CR, Santiago BM, Lima FR, Otaduy MC, Calich AL, Tritto AC, et al. Creatine supplementation in fibromyalgia: a randomized, double-blind, placebo-controlled trial. Arthritis Care Res. 2013;65:1449–59.CrossRef Alves CR, Santiago BM, Lima FR, Otaduy MC, Calich AL, Tritto AC, et al. Creatine supplementation in fibromyalgia: a randomized, double-blind, placebo-controlled trial. Arthritis Care Res. 2013;65:1449–59.CrossRef
41.
Zurück zum Zitat Rawson ES, Venezia AC. Use of creatine in the elderly and evidence for effects on cognitive function in young and old. Amino Acids. 2011;40:1349–62.PubMedCrossRef Rawson ES, Venezia AC. Use of creatine in the elderly and evidence for effects on cognitive function in young and old. Amino Acids. 2011;40:1349–62.PubMedCrossRef
42.
Zurück zum Zitat Kristensen CA, Askenasy N, Jain RK, Koretsky AP. Creatine and cyclocreatine treatment of human colon adenocarcinoma xenografts: 31P and 1H magnetic resonance spectroscopic studies. Br J Cancer. 1999;79:278–85.PubMedCentralPubMedCrossRef Kristensen CA, Askenasy N, Jain RK, Koretsky AP. Creatine and cyclocreatine treatment of human colon adenocarcinoma xenografts: 31P and 1H magnetic resonance spectroscopic studies. Br J Cancer. 1999;79:278–85.PubMedCentralPubMedCrossRef
43.
44.
Zurück zum Zitat Lillie JW, O'Keefe M, Valinski H, Hamlin Jr HA, Varban ML, Kaddurah-Daouk R. Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors. Cancer Res. 1993;53:3172–8.PubMed Lillie JW, O'Keefe M, Valinski H, Hamlin Jr HA, Varban ML, Kaddurah-Daouk R. Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors. Cancer Res. 1993;53:3172–8.PubMed
45.
Zurück zum Zitat Patra S, Bera S, SinhaRoy S, Ghoshal S, Ray S, Basu A, et al. Ray. Progressive decrease of phosphocreatine, creatine and creatine kinase in skeletal muscleupon transformation to sarcoma. FEBS J. 2008;275:3236–47.PubMedCrossRef Patra S, Bera S, SinhaRoy S, Ghoshal S, Ray S, Basu A, et al. Ray. Progressive decrease of phosphocreatine, creatine and creatine kinase in skeletal muscleupon transformation to sarcoma. FEBS J. 2008;275:3236–47.PubMedCrossRef
46.
Zurück zum Zitat Norman K, Stübler D, Baier P, Schütz T, Ocran K, Holm E, et al. Effects of creatine supplementation on nutritional status, muscle function and quality of life in patients with colorectal cancer–a double blind randomised controlled trial. Clin Nutr. 2006;25:596–605.PubMedCrossRef Norman K, Stübler D, Baier P, Schütz T, Ocran K, Holm E, et al. Effects of creatine supplementation on nutritional status, muscle function and quality of life in patients with colorectal cancer–a double blind randomised controlled trial. Clin Nutr. 2006;25:596–605.PubMedCrossRef
Metadaten
Titel
An overview of amines as nutritional supplements to counteract cancer cachexia
verfasst von
Patrícia Lopes de Campos-Ferraz
Isabel Andrade
Willian das Neves
Isabela Hangai
Christiano Robles Rodrigues Alves
Antonio Herbert Lancha Jr
Publikationsdatum
01.06.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cachexia, Sarcopenia and Muscle / Ausgabe 2/2014
Print ISSN: 2190-5991
Elektronische ISSN: 2190-6009
DOI
https://doi.org/10.1007/s13539-014-0138-x

Weitere Artikel der Ausgabe 2/2014

Journal of Cachexia, Sarcopenia and Muscle 2/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.